NCT02047253 2018-12-19Phase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following TreatmentUniversity of Alabama at BirminghamPhase 2 Completed28 enrolled 12 charts
NCT00596895 2011-09-20Isoflavone in Prostate-specific Antigen Recurrent Prostate CancerUniversity of FloridaPhase 2 Completed20 enrolled